Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Completed 3Unknown 1Recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Head & Neck 3Genitourinary 2Sarcoma 1Breast 1

Conditions

Breast Neoplasms 6392Neoplasms 5365Prostatic Neoplasms 2966Carcinoma, Non-Small-Cell Lung 2709Colorectal Neoplasms 2679Lung Neoplasms 2267Multiple Myeloma 1663Lymphoma 1600Neoplasm Metastasis 1552Leukemia, Myeloid, Acute 1540Melanoma 1486Pancreatic Neoplasms 1470Ovarian Neoplasms 1423Leukemia 1389Head and Neck Neoplasms 1284Precursor Cell Lymphoblastic Leukemia-Lymphoma 1282Lymphoma, Non-Hodgkin 1231Colonic Neoplasms 1159Carcinoma, Hepatocellular 1142Stomach Neoplasms 1129Leukemia, Lymphocytic, Chronic, B-Cell 1090Brain Neoplasms 1050Rectal Neoplasms 980Lymphoma, Follicular 979Recurrence 976Uterine Cervical Neoplasms 926Glioblastoma 920Carcinoma, Renal Cell 882Lymphoma, Large B-Cell, Diffuse 853Hodgkin Disease 777

Interventions

Cinacalcet 1Calcifediol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Hyperparathyroidism, Secondary × Clear all
NCT03123406 2024-04-29

ACTIVE

Kyowa Kirin Co., Ltd.

Phase 4 Completed
750 enrolled
GenitourinaryHead & Neck

Hyperparathyroidism, Hyperparathyroidism, Secondary, Neoplasm Metastasis, Chronic Kidney Disease-Mineral and Bone Disorder

NCT02274623 2019-09-27

Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid

OPKO Health, Inc.

Phase 1 Completed
33 enrolled
BreastGenitourinaryHead & NeckSarcoma

Bone Neoplasms, Breast Neoplasms, Hyperparathyroidism, Secondary, Hypocalcemia, Prostatic Neoplasms

NCT01083849 2014-12-19

TOP

AbbVie

Completed
761 enrolled 17 charts
Head & Neck

Hyperparathyroidism, Secondary, Neoplasm Metastasis, Renal Insufficiency, Chronic, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡